182 related articles for article (PubMed ID: 30112608)
1. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.
Albano D; Panarotto MB; Durmo R; Rodella C; Bertagna F; Giubbini R
Endocrine; 2019 Jan; 63(1):79-86. PubMed ID: 30112608
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
[TBL] [Abstract][Full Text] [Related]
3. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma.
Choi YM; Kim WG; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Hong EG; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2016 Sep; 175(3):165-72. PubMed ID: 27272238
[TBL] [Abstract][Full Text] [Related]
4. Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer.
Simões-Pereira J; Mourinho N; Ferreira TC; Limbert E; Cavaco BM; Leite V
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3911-e3922. PubMed ID: 34134139
[TBL] [Abstract][Full Text] [Related]
5. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
Mihailovic J; Stefanovic L; Malesevic M; Markoski B
Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
[TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
7. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors.
Matsuzu K; Sugino K; Masudo K; Mori K; Ono R; Yamazaki H; Masaki C; Akaishi J; Kiyomi Yamada H; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2020 Aug; 67(8):869-876. PubMed ID: 32350192
[TBL] [Abstract][Full Text] [Related]
9. Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer.
Alzahrani AS; Mohamed G; Al Shammary A; Aldasouqi S; Abdal Salam S; Shoukri M
J Endocrinol Invest; 2005 Jun; 28(6):540-6. PubMed ID: 16117196
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
[TBL] [Abstract][Full Text] [Related]
11. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
[No Abstract] [Full Text] [Related]
12. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
Elisei R; Molinaro E; Agate L; Bottici V; Masserini L; Ceccarelli C; Lippi F; Grasso L; Basolo F; Bevilacqua G; Miccoli P; Di Coscio G; Vitti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1516-27. PubMed ID: 20156922
[TBL] [Abstract][Full Text] [Related]
13. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
14. Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape.
Nies M; Vassilopoulou-Sellin R; Bassett RL; Yedururi S; Zafereo ME; Cabanillas ME; Sherman SI; Links TP; Waguespack SG
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1683-e1697. PubMed ID: 33382403
[TBL] [Abstract][Full Text] [Related]
15. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
[TBL] [Abstract][Full Text] [Related]
16. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades.
Goffredo P; Sosa JA; Roman SA
World J Surg; 2013 Jul; 37(7):1599-605. PubMed ID: 23525600
[TBL] [Abstract][Full Text] [Related]
18. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
Claimon A; Pusuwan P; Khiewvan B
J Med Assoc Thai; 2017 Feb; 100(2):207-18. PubMed ID: 29916638
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
20. The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer.
Albano D; Dondi F; Zilioli V; Panarotto MB; Galani A; Cappelli C; Bertagna F; Giubbini R; Casella C
Ann Nucl Med; 2021 Oct; 35(10):1089-1099. PubMed ID: 34152569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
